This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In The Journal, March 18, 1916, p. 867, Ormsby and Mitchell of Chicago reported on the comparison between salvarsan and arsenobenzol. I was one of the first who through Dr. Schamberg's kindness was able to give this drug an extensive trial, and according to his statement have at the present time had perhaps the largest experience with it. Inasmuch as the Philadelphia product is about to be issued to the medical profession at large, it seems proper to supplement the Ormsby-Mitchell report in order to apprise the profession that the remedy may be used with perfect safety. The cases reported herein have been studied with two main considerations in view: first, the possible toxicity of the new drug, and second, its relative therapeutic value as compared with old salvarsan.
During the past six months, 243 cases of syphilis have been treated at the University Hospital with arsenobenzol. These patients have
Wile UJ. A Report on the Efficiency and Nontoxicity of Arsenobenzol. JAMA. 1916;LXVI(24):1880. doi:10.1001/jama.1916.02580500058023
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: